$10.010
+0.050 (+0.50%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
ALPX 相似圖表分析預測
Alphio's ALPX stock price prediction model matches the current Alpex Acquisition Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.05 (+0.36%). The 1-week path is $10.24 (+2.30%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Alpex Acquisition Corp 股票嗎?
Alpex Acquisition Corp is not a good buy right now due to its negative fundamentals and lack of strong momentum. The current price is $9.98, and the stock has a forward P/E of 0, indicating no expected earnings growth. Additionally, the RSI is at 58.458, suggesting it is nearing overbought territory. The main risk is the negative P/E ratio of -77.65, which indicates the company is currently unprofitable, making it a risky investment.
ALPX 股價於 Thursday 收在 $10.01,此前上漲 +0.50%
Alpex Acquisition Corp (ALPX) last closed at $10.0100002, gaining +0.50%. These facts feed the 1-day and 1-week ALPX price prediction above.
預測驅動因素
Alpex Acquisition Corp(ALPX)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 ALPX 最接近的股票,依相似度排序。
ALPX 季節性分析
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。